Dmitri Belov
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Natural Antidiabetic Agents Studies
Papers in
-
- Advanced Glycation End Products research 3
- Co-authors
- Ann Marie SchmidtShi Fang YanYoshifumi NakaPeter P. NawrothTaichi SakaguchiMartin AndrassyShi Du YanLing Rong
- Journals
- Journal of Clinical Investigation (3 papers)Journal of Thoracic and Cardiovascular Surgery (1 paper)Journal of the American College of Cardiology (1 paper)Circulation (1 paper)Circulation Research (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Dmitri Belov
6 papers receiving 896 citations
Peers
Comparison fields: 5 of 66
- Clinical Biochemistry 667
- Endocrinology, Diabetes and Metabolism 253
- Nephrology 77
- Immunology 160
- Neurology 52
Countries citing papers authored by Dmitri Belov
This map shows the geographic impact of Dmitri Belov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitri Belov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitri Belov more than expected).
Fields of papers citing papers by Dmitri Belov
This network shows the impact of papers produced by Dmitri Belov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitri Belov. The network helps show where Dmitri Belov may publish in the future.
Co-authors
The 25 scholars most cited alongside Dmitri Belov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2020 | 1 | |
| 4 | 2008 | 305 | |
| 5 | 2005 | 21 | |
| 6 | 2004 | 15 | |
| 7 | 2003 | 296 | |
| 8 | 2003 | 265 |
About Dmitri Belov
Dmitri Belov is a scholar working on Clinical Biochemistry, Immunology and Allergy, Neurology, Ophthalmology and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 903 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (3 papers), S100 Proteins and Annexins (3 papers), Acute Ischemic Stroke Management (2 papers), Protein Kinase Regulation and GTPase Signaling (1 paper), Signaling Pathways in Disease (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Coronary Interventions and Diagnostics (1 paper) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Clinical Biochemistry (667 citations), Endocrinology, Diabetes and Metabolism (253 citations), Nephrology (77 citations), Immunology (160 citations) and Neurology (52 citations). Dmitri Belov has collaborated with scholars based in United States and Germany. Frequent co-authors include Ann Marie Schmidt, Shi Fang Yan, Yoshifumi Naka, Peter P. Nawroth, Taichi Sakaguchi, Martin Andrassy, Shi Du Yan, Ling Rong, David M. Stern and Stephan H. Duda. Their work appears in journals such as Journal of Clinical Investigation, Journal of Thoracic and Cardiovascular Surgery, Journal of the American College of Cardiology, Circulation and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.